Nektar Therapeutics

IRS: 943134940
Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. The company has additional operations facilities in Huntsville, Alabama, and Hyderabad, India.

1990 (32 years)
Investor RelationsSEC
105 million (2021)

Want to see more? Sign up!